Market Research Logo

Serbia Pharmaceuticals & Healthcare Q3 2018

Serbia Pharmaceuticals & Healthcare Q3 2018

BMI View:

Despite Serbia's pharmaceutical market size and outlook placing it as one of the more attractive markets for growthwithin the Balkan region, this sub-region is overshadowed by the far more developed Central and Western European sub-regions.Drugmaker opportunities will remain restricted by a lack of legislative development, while the declining population will limit gains inincreased access to healthcare. Nevertheless, growth will remain robust over the long-term, as the sector and the country’seconomy develops.


BMI Industry View
SWOT
Industry Forecast
Pharmaceuticals Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Galenika
Hemofarm Stada
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report